Asthma Canada continues to work toward a future without asthma by contributing to research efforts across the country.
Canadian Delphi Study
As part of the PRECISION programme, Asthma Canada helped to develop a Delphi consensus project to define standards of care for severe asthma in Canada, in areas where the evidence is lacking through patient and healthcare professional consensus, to complement forthcoming guidelines. Implementation of these recommendations across the severe asthma care pathway in Canada has the potential to improve outcomes for patients through earlier detection of undiagnosed severe asthma, reduction in time to severe asthma diagnosis, and initiation of advanced phenotype specific therapies.
2022 Community Feedback Report
We asked: how are we doing?
We connected with our community through an online survey to ask what they are most interested in, which of our programs and services they find most helpful, and what they would like to see more of from Asthma Canada.
Community Check-in Report: Post-Lockdown in the “New Normal”
We connected with our community through an online survey to understand ongoing asthma management and experience as COVID-related restrictions and policies lifted and changed throughout most parts of Canada in 2022.
A Snapshot of Asthma in Canada: 2021 Annual Asthma Survey Report
Asthma Canada Access to Health Care amid COVID-19
In March 2021, we reached out to our community with an invitation to share their experience of accessing health care during the pandemic.
Asthma Canada 2020 Annual Asthma Survey Report: A Snapshot of Asthma in Canada
When Asthma Canada began preparing to launch our 2020 survey, we had no idea what the year would have in store for us. It is safe to say that 2020 is a year unlike any other. The voices of our asthma community — including patients, parents, caregivers and healthcare providers — are especially important during these difficult times, and Asthma Canada continues to meet the changing needs of our community.
A Snapshot of Asthma in Canada: 2019 Annual Asthma Survey Report
Our inaugural annual survey report, A Snapshot of Asthma in Canada, revealed the far-reaching impacts of asthma on the health and everyday lives of Canadians. The report shows that lack of access to medications and proper management are critical issues in the community. Associated conditions like mental health issues are impacting the overall management of asthma. Three high-risk groups were identified: people with low income, those with Severe Asthma, and young adults between 18 and 34 living with asthma, who are disproportionately impacted by the disease.
Severe Asthma: The Canadian Patient Journey
Our study, Severe Asthma: The Canadian Patient Journey revealed the social, financial and health impacts of Severe Asthma on the lives of Canadians. This landmark study is now used to educate, raise awareness and advocate on behalf of the estimated 150,000 – 250,000 Canadians living with Severe Asthma.
Read the report:
Mapping the Patient Journey: A Guide based on the Severe Asthma Study
Mapping the Patient Journey is meant to be used by global and national organizations in collaboration with community partners and patient population group(s) of interest to implement the Severe Asthma Study in order to map out the patient(s) journey with a severe health condition.
Mapping the Patient Journey includes a program background with detailed information about the Severe Asthma Study, the conception of the study, goals and outcomes, as well as detailed information on the process taken to implement the study.
Read the report: Full Report
Characteristics of Patients with Mild to Severe Asthma in Canada
We support collaboration with community and corporate partners on research that furthers treatment options. In 2016 we worked with Teva Canada in an epidemiological study of the patterns, causes and effects of eosinophilic asthma to better understand the size and scale of the Severe Asthma community. We are proud to have been a part of this study, which leads to a better understanding of eosinophils, a biomarker found in the blood and its relation to asthma, which may lead to the development of more personalized treatments.
Asthma Canada’s National Research Program invests in Canadian asthma research through annual Lead Investigator Awards and Graduate Student Research Grants. By investing in research, we take one step closer to a future without asthma.